TrialHepatology international2025

Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks.

Zhili Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.